New York Heart Association functional class predicts exercise parameters in the current era

American Heart Journal

Volumn 158, Issue 4 SUPPL., 2009, Pages

  Russell, Stuart D ^a   Saval, Matthew A ^b   Robbins, Jennifer L ^c   Ellestad, Myrvin H ^d   Gottlieb, Stephen S ^e   Handberg, Eileen M ^f   Zhou, Yi ^g   Chandler, Bleakley ^h  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b HENRY FORD HOSPITAL   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d Memorial Heart & Vascular Institute   (United States)

^e UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF FLORIDA   (United States)

^g DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^h University Hospital Augusta   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ANGINA PECTORIS; ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL ASSESSMENT TOOL; CLINICAL EVALUATION; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; DYSPNEA; EXERCISE; EXERCISE TEST; FATIGUE; FUNCTIONAL STATUS; HEART ARRHYTHMIA; HEART EJECTION FRACTION; HEART FAILURE; HEART MUSCLE OXYGEN CONSUMPTION; HUMAN; HYPERTENSION; ISCHEMIA; LUNG VENTILATION PERFUSION RATIO; MAJOR CLINICAL STUDY; METABOLIC STRESS; MUSCULOSKELETAL DISEASE; PRIORITY JOURNAL;

ADRENERGIC BETA-ANTAGONISTS; ALDOSTERONE ANTAGONISTS; CARDIAC PACING, ARTIFICIAL; DATA COLLECTION; ELECTROCARDIOGRAPHY; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HEART; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; PULMONARY VENTILATION; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 70349282152     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2009.07.017     Document Type: Article

References (27)

1. The Criteria Committee of the New York Heart Association. In: Dulgan M. (Ed). Nomenclature and criteria for diagnosis of diseases of the heart and great vessels. 9th ed. (1994), Little, Brown & Co, Boston (Mass) 253-256
2. Adams K.F., Lindenfeld J., Arnold J.M.O., et al. Executive Summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail 12 (2006) 10-38
3. Kubo S.H., Schulman S., Starling R.C., et al. Development and validation of a patient questionnaire to determine New York Heart Association classification. J Cardiac Fail 10 (2004) 228-235
4. Fleg J.L., Pina I.L., Balady G.J., et al. Assessment of functional capacity in clinical and research applications. An advisory from the Committee on Exercise, Rehabilitation, and Prevention Council on Clinical Cardiology, American Heart Association. Circulation 102 (2000) 1591-1597
5. Mancini D.M., Eisen H., Kussmaul W., et al. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 83 (1991) 778-786
6. Myers J., Arena R., Dewey F., et al. A cardiopulmonary exercise testing score for predicting outcomes in patients with heart failure. Am Heart J 156 (2008) 1177-1183
7. Mehra M.R., Kobashigawa J., Starling R., et al. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates-2006. J Heart Lung Transplant 25 (2006) 1024-1042
8. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353 (1999) 2001-2007
9. Packer M., Coats A.J.S., Fowler M.B., et al., For the Carvedilol Prospective Randomized Cumulative Survival Study Group. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 344 (2001) 1651-1658
10. Pitt B., Zannad F., Remme W.J., et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341 (1999) 709-717
11. Bristow M.R., Saxon L.A., Boehmer J., et al., For the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Eng J Med 350 (2004) 2140-2150
12. Bardy G.H., Lee K.L., Mark D.B., et al., For the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Eng J Med 352 (2005) 225-237
13. Gullestad L., Manhenke C., Aarsland T., et al. Effect of metoprolol CR/XL on exercise tolerance in chronic heart failure-a substudy to the MERIT-HF trial. Eur J Heart Fail 3 (2001) 463-468
14. Young J.B., Abraham W.T., Smith A.L., et al., For the Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA 289 (2003) 2685-2694
15. Abraham W.T., Young J.B., Leon A.R., et al. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure. Circulation 110 (2004) 2864-2868
16. Peterson L.R., Schechtman K.B., Ewald G.A., et al. Timing of cardiac transplantation in patients with heart failure receiving b-adrenergic blockers. J Heart Lung Transplant 22 (2003) 1141-1148
17. Whellan D.J., O'Connor C.M., Lee K.L., et al. Heart failure and a controlled trial investigating outcomes of exercise training (HF-ACTION): design and rationale. Am Heart J 153 (2007) 201-211
18. Higginbotham M.B. Cardiovascular applications for cardiopulmonary exercise testing. Cont Int Med 12 (1995) 16-27
19. Chua T.P., Ponikowski P., Harrington D., et al. Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol 29 (1997) 1585-1590
20. Robbins M., Francis G., Pashkow R.J., et al. Ventilatory and heart rate responses to exercise. Better predictors of heart failure mortality than peak oxygen consumption. Circulation 100 (1999) 2411-2417
21. 2. Eur Heart J 21 (2000) 154-161
22. 2 slope in patients with heart failure: a prognostic comparison. Am Heart J 147 (2004) 354-360
23. Arena R., Myers J., and Guazzi M. The clinical and research applications of aerobic capacity and ventilatory efficiency in heart failure: an evidence-based review. Heart Fail Rev 13 (2008) 245-269
24. Weber K.T., Kinasewitz G.T., Janicki J.S., et al. Oxygen utilization and ventilation during exercise in patients with chronic cardiac failure. Circulation 65 (1982) 1213-1223
25. Williams S.G., Ng L.L., O'Brien R.J., et al. Complementary roles of simple variables, NYHA and N-BNP, in indicating aerobic capacity and severity of heart failure. Int J Cardiol 102 (2005) 279-286
26. Lindenfeld J., Feldman A.M., Saxon L., et al. Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure. Circulation 115 (2007) 204-212
27. Narang R., Swedberg K., and Cleland J.G. What is the ideal study design for evaluation of treatment for heart failure? Insights from trials assessing the effect of ACE inhibitors on exercise capacity. Eur Heart J 17 (1996) 120-134